KESIMPTA PEN (ofatumumab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · RELAPSING FORM OF MULTIPLE SCLEROSIS ·+1
Novartis Pharmaceuticals
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
SIMULECT (basiliximab)
MONOCLONAL ANTIBODY IMMUNOSUPPRESSIVES · PREVENTION OF KIDNEY TRANSPLANT REJECTION
Novartis Pharmaceuticals
OCREVUS (ocrelizumab)
MONOCLONAL ANTIBODY IMMUNOSUPPRESSIVES · RELAPSING REMITTING MULTIPLE SCLEROSIS ·+3
GENENTECH
KESIMPTA PEN (ofatumumab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES · RELAPSING FORM OF MULTIPLE SCLEROSIS ·+1
Novartis Pharmaceuticals
BRIUMVI (ublituximab-xiiy)
MONOCLONAL ANTIBODY IMMUNOSUPPRESSIVES · RELAPSING FORM OF MULTIPLE SCLEROSIS
TG THERAPEUTICS
OCREVUS ZUNOVO (ocrelizumab-hyaluronidase-ocsq)
MONOCLONAL ANTIBODY IMMUNOSUPPRESSIVES · RELAPSING REMITTING MULTIPLE SCLEROSIS ·+3
GENENTECH
SIMULECT (basiliximab)
MONOCLONAL ANTIBODY IMMUNOSUPPRESSIVES · PREVENTION OF KIDNEY TRANSPLANT REJECTION
Novartis Pharmaceuticals